{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:22:09Z","timestamp":1780086129882,"version":"3.54.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004476","name":"Chinese Center for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10713003"],"award-info":[{"award-number":["2018ZX10713003"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.026","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T13:36:38Z","timestamp":1623850598000},"page":"4328-4334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigation of the baseline tetanus antibody level and its persistence in a military unit"],"prefix":"10.1016","volume":"39","author":[{"given":"Libo","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshuai","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuiyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuandong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.06.026_b0005","first-page":"719","article-title":"Surveillance on tetanus antibody levels of 1003 migrant factory workers in Shenzhen","volume":"10","author":"Qiu","year":"2010","journal-title":"J Trop Med"},{"key":"10.1016\/j.vaccine.2021.06.026_b0010","first-page":"3573","article-title":"Tetanus vaccines: WHO position paper, February 2017\u2014Recommendations","volume":"6","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.026_b0015","first-page":"468","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older\u2014advisory committee on immunization practices (ACIP), 2012","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2021.06.026_b0020","unstructured":"Chen QZ, Lin GW. Practice internal medicine. 2013. Beijing: People\u2019s Medical Publishing House; 2009, p. 649\u201351."},{"key":"10.1016\/j.vaccine.2021.06.026_b0025","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1016\/j.vaccine.2009.06.080","article-title":"High tetanus and diphtheria antitoxin concentrations in Finnish adults\u2014Time for new booster recommendations?","volume":"27","author":"\u00d6lander","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.026_b0030","first-page":"415","article-title":"Monitoring analysis of national immunization program vaccine antibody levels in healthy people of Wuhai City Inner Mongolia","volume":"33","author":"Wang","year":"2017","journal-title":"J Med Pest Control"},{"key":"10.1016\/j.vaccine.2021.06.026_b0035","first-page":"1242","article-title":"The serological surveillance of tetanus antibodies among Guangzhou people in 2016","volume":"18","author":"Zhang","year":"2018","journal-title":"J Trop Med"},{"key":"10.1016\/j.vaccine.2021.06.026_b0040","first-page":"822","article-title":"Investigation on tetanus antibody levels in healthy plasma donors","volume":"27","author":"Sun","year":"2014","journal-title":"Chin J Biologicals"},{"key":"10.1016\/j.vaccine.2021.06.026_b0045","first-page":"9","article-title":"Practical issues in calculating the sample size for prevalence studies","volume":"1","author":"Naing","year":"2006","journal-title":"Arch Orofac Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.026_b0050","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciw066","article-title":"Durability of vaccine-induced immunity against tetanus and diphtheria toxins: A cross-sectional analysis","volume":"629","author":"Hammarlund","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.026_b0055","series-title":"Infectious diseases","author":"Wang","year":"2005"},{"key":"10.1016\/j.vaccine.2021.06.026_b0060","series-title":"Vaccinology","author":"Zhang","year":"2006"},{"key":"10.1016\/j.vaccine.2021.06.026_b0065","first-page":"159","article-title":"Global immunization schedules, vaccination coverage rates and incidences of diphtheria, tetanus and pertussis, 2010\u20132014","volume":"22","author":"Ning","year":"2016","journal-title":"Chin J Vaccines Immunization (China)"},{"key":"10.1016\/j.vaccine.2021.06.026_b0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exger.2017.08.037","article-title":"Protection against tetanus and diphtheria in Europe: The impact of age, gender and country of origin based on data from the MARK-AGE study","volume":"105","author":"Weinberger","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.vaccine.2021.06.026_b0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10903-008-9123-9","article-title":"Evaluation for tetanus antibodies in Korean-Americans living in the New York area: A pilot study","volume":"11","author":"Alagappan","year":"2009","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/j.vaccine.2021.06.026_b0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2334-12-138","article-title":"The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: A cross sectional study","volume":"12","author":"Zhang","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.026_b0085","first-page":"705","article-title":"Epidemiological and clinical characteristics changes of 47 cases of tetanus","volume":"16","author":"Su","year":"2015","journal-title":"J Clin Emerg (China)"},{"key":"10.1016\/j.vaccine.2021.06.026_b0090","unstructured":"National Health and Family Planning Commission. Standard operational procedures for immunization (2016), https:\/\/so.kaipuyun.cn\/s?database=zcwj&siteCode=bm24000006&qt=%E9%A2%84%E9%98%B2%E6%8E%A5%E7%A7%8D%E8%A7%84%E8%8C%832016&noTools=true [accessed 12 June 2016]."},{"key":"10.1016\/j.vaccine.2021.06.026_b0095","first-page":"264","article-title":"Surveillance and analysis of diphtheria antibody in healthy population during 1996\u20132000 in Beijing","volume":"8","author":"Wang","year":"2002","journal-title":"Chin J Vaccines Immunization (China)"},{"key":"10.1016\/j.vaccine.2021.06.026_b0100","first-page":"68","article-title":"Observation of immunity level of pertussis-diphtheria-tetanus in healthy people in Hangzhou City during 1995\u20132006","volume":"15","author":"Huang","year":"2009","journal-title":"Chin J Vaccines Immunization (China)"},{"key":"10.1016\/j.vaccine.2021.06.026_b0105","first-page":"1541","article-title":"A seroepidemiology study of tetanus antibody level in the population of recruits","volume":"38","author":"Yu","year":"2011","journal-title":"Modern Prev Med (China)"},{"key":"10.1016\/j.vaccine.2021.06.026_b0110","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.vaccine.2006.09.084","article-title":"Tetanus in the elderly-An important preventable disease in Australia","volume":"25","author":"Quinn","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.026_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-0500-3-8","article-title":"Characteristic tetanus infection in disaster-affected areas: Case study of the Yogyakarta earthquakes in Indonesia","volume":"3","author":"Sutiono","year":"2010","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2021.06.026_b0120","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.vaccine.2018.03.029","article-title":"Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA","volume":"36","author":"Pool","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.026_b0125","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1016\/j.vaccine.2014.08.005","article-title":"Humoral responses to independent vaccinations are correlated in healthy boosted adults","volume":"32","author":"Garman","year":"2014","journal-title":"Vaccine"},{"issue":"143\u201353","key":"10.1016\/j.vaccine.2021.06.026_b0130","first-page":"ix","article-title":"Issues related to the decennial tetanus-diphtheria toxoid booster recommendations in adults","volume":"15","author":"Gardner","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2021.06.026_b0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF02599616","article-title":"Should adult tetanus immunization be given as a single vaccination at age 65? A cost-effectiveness analysis","volume":"8","author":"Balestra","year":"1993","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2021.06.026_b0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF02599628","article-title":"Routine tetanus immunizations for adults: Once is enough","volume":"8","author":"LaForce","year":"1993","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2021.06.026_b0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healthpol.2010.11.013","article-title":"Tetanus seroepidemiology and factors influencing immunity status among farmers of advanced age","volume":"100","author":"\u00d6nc\u00fc","year":"2011","journal-title":"Health Policy"},{"key":"10.1016\/j.vaccine.2021.06.026_b0150","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"issue":"145","key":"10.1016\/j.vaccine.2021.06.026_b0155","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1017\/S0950268817000516","article-title":"Tetanus vaccination, antibody persistence and decennial booster: A serosurvey of university students and at-risk workers","author":"Borella-Venturini","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.06.026_b0160","first-page":"991","article-title":"Expert consensus on prophylaxis, diagnosis and management of tetanus among adults","volume":"43","author":"Zhang","year":"2018","journal-title":"Med J Chin PLA"},{"key":"10.1016\/j.vaccine.2021.06.026_b0165","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1016\/j.vaccine.2018.09.041","article-title":"Tetanus-diphtheria vaccination in adults: The long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1\u204401","volume":"36","author":"Ferlito","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.026_b0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0196-0644(85)80732-0","article-title":"Comparison of the morbidity tetanus toxoid boosters with tetanus-diphtheria boosters","volume":"14","author":"Macko","year":"1985","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.vaccine.2021.06.026_b0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.pubmed.a043782","article-title":"Adverse reactions in adolescents to reinforcing doses of plain and adsorbed tetanus vaccines","volume":"7","author":"Jones","year":"1985","journal-title":"J Public Health"},{"issue":"265","key":"10.1016\/j.vaccine.2021.06.026_b0180","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM196112072652307","article-title":"Adult immunization: Dosage reduction as a solution to increasing reactions to tetanus toxoid","author":"McComb","year":"1961","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.026_b0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0022172400022750","article-title":"Reactions to tetanus toxoid","volume":"71","author":"White","year":"1973","journal-title":"J Hygiene"},{"key":"10.1016\/j.vaccine.2021.06.026_b0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF01710736","article-title":"Prevalence of hyperimmunization against tetanus in Italians born after the introduction of mandatory vaccination of children with tetanus toxoid in 1968","volume":"21","author":"Gentili","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2021.06.026_b0195","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000236967","article-title":"IgE antibodies to tetanus toxoid in relation to atopy","volume":"107","author":"Aalberse","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.026_b0200","first-page":"441","article-title":"World Health Organization opinion on tetanus vaccine","volume":"32","author":"Gong","year":"2017","journal-title":"Disease Surveill"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.026_b0205","first-page":"9","article-title":"Study on the intervention effects of immunoprophylaxis knowledge among the children\u2019s parents in Community","volume":"21","author":"Han","year":"2009","journal-title":"Zhejiang Prev Med"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.026_b0210","first-page":"83","article-title":"Status quo and its influencing factors for four types of adult vaccination in China from 2014 to 2019","volume":"34","author":"Xu","year":"2020","journal-title":"Chin Prim Health Care"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:58:59Z","timestamp":1759402739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":42,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007623"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the baseline tetanus antibody level and its persistence in a military unit","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}